During this project, the researchers took a mouse monoclonal antibody called ... inoculated with commercially available ovarian cancer cell lines, and a second that had been inoculated with ...

Deeper knowledge of the biology of ovarian cancer has led to the identification of multiple molecular targets, such as growth factor receptors, signal transduction pathways, cell cycle regulators ...

SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) ("CERo”), an innovative immunotherapy company seeking to advance the next generation of ...

In mouse xenograft studies using a CCNE-amplified ovarian cancer cell line or patient-derived tumors, ETX-197/BG-68501 showed sustained target engagement, dose-dependent tumor growth inhibition ...